Published in Am J Physiol on June 01, 1990
Temporal effects of catalase overexpression on healing after myocardial infarction. Circ Heart Fail (2010) 0.86
Myeloperoxidase activity as a quantitative assessment of neutrophil infiltration into ischemic myocardium. J Pharmacol Methods (1985) 3.67
International, open-label, noncomparative, clinical trial of micafungin alone and in combination for treatment of newly diagnosed and refractory candidemia. Eur J Clin Microbiol Infect Dis (2005) 2.34
Role of leukocytes in acute myocardial infarction in anesthetized dogs: relationship to myocardial salvage by anti-inflammatory drugs. J Pharmacol Exp Ther (1984) 2.12
Leukocytes and ischemia-induced myocardial injury. Annu Rev Pharmacol Toxicol (1986) 1.61
Exudation primes human and guinea pig neutrophils for subsequent responsiveness to the chemotactic peptide N-formylmethionylleucylphenylalanine and increases complement component C3bi receptor expression. J Clin Invest (1986) 1.41
Genetic hypertension in rats is accompanied by a defect in renal prostaglandin catabolism. Nature (1976) 1.41
Arachidonic acid-induced endothelial-dependent relaxations of canine coronary arteries: contribution of a cytochrome P-450-dependent pathway. J Pharmacol Exp Ther (1987) 1.40
Induction of T cell activation by monoclonal anti-Thy-1 antibodies. J Immunol (1986) 1.30
Accelerated neutrophil apoptosis in the acquired immunodeficiency syndrome. J Clin Invest (1996) 1.30
Human neutrophil heterogeneity identified using flow microfluorometry to monitor membrane potential. J Clin Invest (1981) 1.26
Leukocyte-derived metabolites of arachidonic acid in ischemia-induced myocardial injury. Fed Proc (1987) 1.11
Nafazatrom-induced salvage of ischemic myocardium in anesthetized dogs is mediated through inhibition of neutrophil function. Circ Res (1985) 1.10
Presence of cytochrome P-450-dependent monooxygenase in intimal cells of the hog aorta. Hypertension (1986) 1.09
Reaction times are faster in HIV-seropositive patients on antiretroviral therapy: A preliminary report. J Clin Exp Neuropsychol (1999) 1.07
Peptide-encoding for structure determination of nonsequenceable polymers within libraries synthesized and tested on solid-phase supports. Pept Res (1993) 1.07
Contribution of oxygen-derived free radicals to experimental necrotizing enterocolitis. Am J Pathol (1988) 1.02
The salvage of ischaemic myocardium by BW755C in anaesthetised dogs. Prostaglandins (1982) 1.02
Cytochrome P-450-dependent monooxygenase activity and endothelial-dependent relaxations induced by arachidonic acid. J Pharmacol Exp Ther (1986) 1.01
Prostacyclin release and the modulation of some vasoactive hormones. Prostaglandins (1980) 1.00
Secretagogue modulation of the response of human neutrophils to chemoattractants: studies with a membrane potential sensitive cyanine dye. Mol Immunol (1980) 0.98
Biotransformation and cardiovascular effects of arachidonic acid in the dog. Eur J Pharmacol (1979) 0.97
Neutrophil depletion suppresses 111In-labeled platelet accumulation in infarcted myocardium. J Cardiovasc Pharmacol (1985) 0.95
Protective effect of an adenosine kinase inhibitor in septic shock. J Immunol (1994) 0.94
Delayed recognition memory span in HIV-1 infection. J Int Neuropsychol Soc (1995) 0.93
Verbal working memory in HIV-seropositive drug users. J Int Neuropsychol Soc (2000) 0.92
One-bead-one-structure combinatorial libraries. Biopolymers (1995) 0.92
Implications of prostacyclin generation for modulation of vascular tone. Clin Sci Mol Med Suppl (1978) 0.92
Inhibition of neutrophil adhesion by adenosine and an adenosine kinase inhibitor. The role of selectins. J Immunol (1995) 0.91
Organelle-depleted human neutrophil cytoplasts used to study fmet-leu-phe receptor modulation and cell function. J Immunol (1984) 0.91
Dual activation of adenosine A1 and A3 receptors mediates preconditioning of isolated cardiac myocytes. Eur J Pharmacol (1997) 0.90
Information processing and antiretroviral therapy in HIV-1 infection. J Int Neuropsychol Soc (1998) 0.89
Differential binding of chemoattractant peptide to subpopulations of human neutrophils. J Immunol (1984) 0.89
The pharmacophore of the human C5a anaphylatoxin. Protein Sci (1994) 0.88
The interactions of platelet-derived mediators on isolated canine coronary arteries. Eur J Pharmacol (1982) 0.88
Polymorphonuclear leukocyte heterogeneity in neonates and adults. Blood (1986) 0.87
Acadesine extends the window of protection afforded by ischaemic preconditioning in conscious rabbits. Cardiovasc Res (1995) 0.87
Endothelium, arachidonic acid, and coronary vascular tone. Fed Proc (1987) 0.87
Working memory deficits in HIV-seropositive drug users. J Int Neuropsychol Soc (1997) 0.86
Prostacyclin can either increase or decrease heart rate depending on the basal state. Br J Pharmacol (1982) 0.86
Adenosine-mediated inhibition of platelet aggregation by acadesine. A novel antithrombotic mechanism in vitro and in vivo. J Clin Invest (1994) 0.85
Acadesine and myocardial protection. Studies of time of administration and dose-response relations in the rat. Circulation (1992) 0.85
Impaired endothelium-dependent relaxations in rabbits subjected to aortic coarctation hypertension. Hypertension (1987) 0.84
Sustained protection by acadesine against ischemia- and reperfusion-induced injury. Studies in the transplanted rat heart. Circulation (1992) 0.84
Conversion of arachidonic acid to two novel products by a cytochrome P450-dependent mixed-function oxidase in polymorphonuclear leukocytes. Biochem Biophys Res Commun (1984) 0.84
A high-density quantitative nuclease protection microarray platform for high throughput analysis of gene expression. J Biotechnol (2011) 0.84
Platelet depletion and infarct size in an occlusion-reperfusion model of myocardial ischemia in anesthetized dogs. J Cardiovasc Pharmacol (1985) 0.83
Adenosine activates A2 receptors to inhibit neutrophil adhesion and injury to isolated cardiac myocytes. J Immunol (1995) 0.83
Impaired phagocyte oxidative capacity in patients with human immunodeficiency virus infection. J Lab Clin Med (1998) 0.82
Characterization of the binding of Bolton-Hunter labeled [125I]C5a to human neutrophil, monocyte and U-937 cell membranes. Mol Immunol (1992) 0.81
Thromboxane synthase inhibition enhances action of converting enzyme inhibitors. Hypertension (1989) 0.81
Acadesine extends the window of protection afforded by ischaemic preconditioning. Cardiovasc Res (1994) 0.81
Alleviation of myocardial stunning by leukocyte and platelet depletion. Circulation (1989) 0.81
Release of a neutrophil-derived vasoconstrictor agent which augments platelet-induced contractions of blood vessels in vitro. Br J Pharmacol (1990) 0.81
Selective defect in human neutrophil superoxide anion generation elicited by the chemoattractant N-formylmethionylleucylphenylalanine in pregnancy. J Infect Dis (1983) 0.80
SOD prevents damage and attenuates eicosanoid release in a rabbit model of necrotizing enterocolitis. Am J Physiol (1988) 0.80
Protection against injury during ischemia and reperfusion by acadesine derivatives GP-1-468 and GP-1-668. Studies in the transplanted rat heart. J Thorac Cardiovasc Surg (1995) 0.80
The role of osmotic pressure and membrane potential in K(+)-stimulated taurine release from cultured astrocytes and LRM55 cells. J Neurosci (1990) 0.80
An antibody binding to human neutrophils demonstrates antigenic heterogeneity detected early in myeloid maturation which correlates with functional heterogeneity of mature neutrophils. J Immunol (1985) 0.80
Prostacyclin-release by bradykinin in vivo [proceedings]. Br J Pharmacol (1979) 0.79
Arachidonic acid monooxygenase and lipoxygenase activities in polymorphonuclear leukocytes. Biochem Pharmacol (1987) 0.79
Modulation of vascular tone by 12(R)-, but not 12(S)-, hydroxyeicosatetraenoic acid. Eur J Pharmacol (1988) 0.79
Prostacyclin mediates the potentiated hypotensive effect of bradykinin following captopril treatment. Eur J Pharmacol (1980) 0.79
Studies on the regulation of GABA synthesis: the interaction of adenine nucleotides and glutamate with brain glutamate decarboxylase. J Neurochem (1978) 0.78
Cardiovascular and renal actions of cytochrome P-450 metabolites of arachidonic acid. Blood Vessels (1989) 0.78
Neutrophils delay functional recovery of the post-hypoxic heart of the rabbit. J Pharmacol Exp Ther (1989) 0.77
Laboratory technics in rabies: Semple-type vaccine. Monogr Ser World Health Organ (1973) 0.77
Isolated coronary-perfused mammalian heart: assessment of eicosanoid and platelet-activating factor release and effects. Methods Enzymol (1990) 0.77
Elimination of prostacyclin (PGI2) and 6-oxo-PGF1 alpha in anaesthetized dogs. J Pharm Pharmacol (1979) 0.77
Reversal of accelerated neutrophil apoptosis and restoration of respiratory burst activity with r-metHuG-CSF (Filgrastim therapy in patients with AIDS. AIDS (1999) 0.77
ATP-dependent calcium transport in rat parotid basolateral membrane vesicles. Modulation by agents which elevate cyclic AMP. J Biol Chem (1986) 0.76
Acadesine prevents oxidant-induced damage in the isolated guinea pig heart. J Pharmacol Exp Ther (1993) 0.76
Prostacyclin release induced by bradykinin may contribute to the antihypertensive action of angiotensin-converting enzyme inhibitors. Adv Prostaglandin Thromboxane Res (1980) 0.76
A marker of neutrophil heterogeneity reveals two forms of chronic myelogenous leukemia. Trans Assoc Am Physicians (1985) 0.75
An antibody to a subpopulation of neutrophils demonstrates antigenic heterogeneity which correlates with response heterogeneity. Trans Assoc Am Physicians (1984) 0.75
Progressive cardiac dysfunction with repeated pacing-induced ischemia: protection by AICA-riboside. Am J Physiol (1991) 0.75
Biotransformation of arachidonic acid in the circulation of the dog [proceedings]. Br J Pharmacol (1978) 0.75
Carbohydrate- and CD18-dependent neutrophil adhesion to cardiac myocytes: effects of adenosine. Cardiovasc Res (1996) 0.75
A neutrophil-derived cytochrome P450-dependent metabolite of arachidonic acid modulates neutrophil behavior. Am J Pathol (1987) 0.75
Recombinant human C5a induces transcription but not translation of interleukin-1 beta mRNA in human monocytes. Res Immunol (1992) 0.75
Recombinant human C5a induces transcription but not translation of interleukin 1 beta mRNA in human monocytes. Lymphokine Cytokine Res (1992) 0.75
Identification of a receptor-binding region in the core segment of the human anaphylatoxin C5a. J Med Chem (1994) 0.75
The interaction of anti-inflammatory drugs with arachidonic acid metabolism. Mater Med Pol (1980) 0.75
Cardioprotection with a novel adenosine regulating agent mediated by intravascular adenosine. Eur J Pharmacol (1997) 0.75
Acadesine (AICA riboside) inhibits platelet aggregation in human whole blood. Adv Exp Med Biol (1991) 0.75
An ex vivo method for studying inflammation in cynomolgus monkeys: analysis of interleukin-1 receptor antagonist. J Pharmacol Toxicol Methods (1996) 0.75
Contribution of prostaglandins to the renal vascular supersensitivity to vasoconstrictor agents exhibited by New Zealand genetic hypertensive rats. Clin Sci Mol Med Suppl (1976) 0.75
Neutrophil activation studied using the two indirect probes of membrane potential which respond by different fluorescence mechanisms. Adv Exp Med Biol (1982) 0.75
Activated human polymorphonuclear leucocytes reduce rabbit papillary muscle function: role of the CD18 glycoprotein adhesion complex. Cardiovasc Res (1991) 0.75
Contribution of leukocytes and platelets to ischemia-induced myocardial damage. Adv Prostaglandin Thromboxane Leukot Res (1985) 0.75
Clinical and magnetic resonance imaging regression of progressive multifocal leukoencephalopathy in an AIDS patient after intensive antiretroviral therapy. J Neuroimaging (2001) 0.75
Acadesine (AICA riboside) attenuates reperfusion injury and oxidant-induced damage of the heart. Adv Exp Med Biol (1991) 0.75